Aberrant circular RNA (circRNA) expression is associated with development of breast cancer. In this study, we aimed to assess the anti-proliferative effect of circ_0119412 knockdown on breast cancer cells.

Material and methods:
Tumor and adjacent normal tissues were collected from 35 patients with invasive breast cancer (mean age: 56 years; mean tumor size: 2 cm; 46% patients with TNM I and II stages). The levels of circ_0119412, microRNA (miR)-1205, and N-acetylgalactosaminyltransferase 6 (GALNT6) were determined using reverse transcription-quantitative polymerase chain reaction. Cell proliferation and invasion were assessed using cell counting kit-8 and transwell assays, respectively. Cell apoptosis was assessed using flow cytometry. Moreover, the targeting relationships of miR-1205 with circ_0119412 and GALNT6 were determined using dual-luciferase reporter and RNA immunoprecipitation assays. Furthermore, tumor growth was observed in an animal model in vivo.

We found that circ_0119412 expression levels were upregulated in breast cancer tumor specimens and cell lines. Downregulation of circ _0119412 inhibited the invasion and proliferation, while enhancing the apoptosis of breast cancer cells. Furthermore, circ_0119412 knockdown suppressed tumor growth in vivo. Notably, miR-1205 was identified as a downstream target of circ_0119412. Downregulation of circ_0119412 suppressed the aggressive behavior of breast cancer cells by targeting miR-1205. Moreover, GALNT6 was the downstream target of miR-1205. Inhibition of miR-1205 aggravated the malignant behavior of breast cancer cells by increasing GALNT6 expression.

Our findings suggest that the downregulation of circ_0119412 inhibits breast cancer progression, at least in part, by targeting the miR-1205/GALNT6 pathway.

Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71: 209-49.
Rivera E, Gomez H. Chemotherapy resistance in metastatic breast cancer: the evolving role of ixabepilone. Breast Cancer Res 2010; 12 (Suppl 2): S2.
Al-Mahmood S, Sapiezynski J, Garbuzenko OB, Minko T. Metastatic and triple-negative breast cancer: challenges and treatment options. Drug Deliv Transl Res 2018; 8: 1483-507.
Weigelt B, Reis-Filho JS. Histological and molecular types of breast cancer: is there a unifying taxonomy? Nat Rev Clin Oncol 2009; 6: 718-30.
Goh JN, Loo SY, Datta A, et al. microRNAs in breast cancer: regulatory roles governing the hallmarks of cancer. Biol Rev Camb Philos Soc 2016; 91: 409-28.
Banin Hirata BK, Oda JM, Losi Guembarovski R, Ariza CB, de Oliveira CE, Watanabe MA. Molecular markers for breast cancer: prediction on tumor behavior. Dis Markers 2014; 2014: 513158.
Greene J, Baird AM, Brady L, et al. Circular RNAs: biogenesis, function and role in human diseases. Front Mol Biosci 2017; 4: 38.
Liu J, Liu T, Wang X, He A. Circles reshaping the RNA world: from waste to treasure. Mol Cancer 2017; 16: 58.
Bolha L, Ravnik-Glavač M, Glavač D. Circular RNAs: biogenesis, function, and a role as possible cancer biomarkers. Int J Genomics 2017; 2017: 6218353.
Yin WB, Yan MG, Fang X, Guo JJ, Xiong W, Zhang RP. Circulating circular RNA hsa_circ_0001785 acts as a diagnostic biomarker for breast cancer detection. Clin Chim Acta 2018; 487: 363-8.
Xu Y, Yao Y, Leng K, et al. Increased expression of circular RNA circ_0005230 indicates dismal prognosis in breast cancer and regulates cell proliferation and invasion via miR-618/CBX8 signal pathway. Cell Physiol Biochem 2018; 51: 1710-22.
He D, Yang X, Kuang W, Huang G, Liu X, Zhang Y. The novel circular RNA Circ-PGAP3 promotes the proliferation and invasion of triple negative breast cancer by regulating the miR-330-3p/Myc Axis. Onco Targets Ther 2020; 13: 10149-59.
Dou D, Ren X, Han M, et al. CircUBE2D2 (hsa_circ_0005728) promotes cell proliferation, metastasis and chemoresistance in triple-negative breast cancer by regulating miR-512-3p/CDCA3 axis. Cancer Cell Int 2020; 20: 454.
Cao L, Wang M, Dong Y, et al. Circular RNA circRNF20 promotes breast cancer tumorigenesis and Warburg effect through miR-487a/HIF-1α/HK2. Cell Death Dis 2020; 11: 145.
Wei J, Wei W, Xu H, et al. Circular RNA hsa_circRNA_102958 may serve as a diagnostic marker for gastric cancer. Cancer Biomark 2020; 27: 139-45.
Panda AC. Circular RNAs act as miRNA Sponges. Adv Exp Med Biol 2018; 1087: 67-79.
Dudekula DB, Panda AC, Grammatikakis I, De S, Abdelmohsen K, Gorospe M. CircInteractome: a web tool for exploring circular RNAs and their interacting proteins and microRNAs. RNA Biol 2016; 13: 34-42.
Yan H, Chen X, Li Y, et al. MiR-1205 functions as a tumor suppressor by disconnecting the synergy between KRAS and MDM4/E2F1 in non-small cell lung cancer. Am J Cancer Res 2019; 9: 312-29.
Yang M, Li G, Fan L, Zhang G, Xu J, Zhang J. Circular RNA circ_0034642 elevates BATF3 expression and promotes cell proliferation and invasion through miR-1205 in glioma. Biochem Biophys Res Commun 2019; 508: 980-5.
Lee S, Vasudevan S. Post-transcriptional stimulation of gene expression by microRNAs. Adv Exp Med Biol 2013; 768: 97-126.
Liu C, Li Z, Xu L, et al. GALNT6 promotes breast cancer metastasis by increasing mucin-type O-glycosylation of 2M. Aging (Albany NY) 2020; 12: 11794-811.
Mao Y, Zhang Y, Fan S, et al. GALNT6 promotes tumorigenicity and metastasis of breast cancer cell via-catenin/MUC1-C signaling pathway. Int J Biol Sci 2019; 15: 169-82.
Lin TC, Chen ST, Huang MC, et al. GALNT6 expression enhances aggressive phenotypes of ovarian cancer cells by regulating EGFR activity. Oncotarget 2017; 8: 42588-601.
Pan G, Mao A, Liu J, Lu J, Ding J, Liu W. Circular RNA hsa_circ_0061825 (circ-TFF1) contributes to breast cancer progression through targeting miR-326/TFF1 signalling. Cell Prolif 2020; 53: e12720.
Sang Y, Chen B, Song X, et al. circRNA_0025202 regulates tamoxifen sensitivity and tumor progression via regulating the miR-182-5p/FOXO3a axis in breast cancer. Mol Ther 2019; 27: 1638-52.
Zeng K, He B, Yang BB, et al. The pro-metastasis effect of circANKS1B in breast cancer. Mol Cancer 2018; 17: 160.
Li R, Wu B, Xia J, Ye L, Yang X. Circular RNA hsa_circRNA_102958 promotes tumorigenesis of colorectal cancer via miR-585/CDC25B axis. Cancer Manag Res 2019; 11: 6887-93.
Wang G, Zhang H, Li P. Upregulation of hsa_circRNA_102958 indicates poor prognosis and promotes ovarian cancer progression through miR-1205/SH2D3A axis. Cancer Manag Res 2020; 12: 4045-53.
Zhong W, Bao L, Yuan Y, Meng Y. CircRASSF2 acts as a prognostic factor and promotes breast cancer progression by modulating miR-1205/HOXA1 axis. Bioengineered 2021; 12: 3014-28.
Guo Y, Shi J, Zhang J, Li H, Liu B, Guo H. Polypeptide N-acetylgalactosaminyltransferase-6 expression in gastric cancer. Onco Targets Ther 2017; 10: 3337-44.
Sheta R, Bachvarova M, Plante M, et al. Altered expression of different GalNAc transferases is associated with disease progression and poor prognosis in women with high-grade serous ovarian cancer. Int J Oncol 2017; 51: 1887-97.
Park JH, Nishidate T, Kijima K, et al. Critical roles of mucin 1 glycosylation by transactivated polypeptide N-acetylgalactosaminyltransferase 6 in mammary carcinogenesis. Cancer Res 2010; 70: 2759-69.
Kimura R, Yoshimaru T, Matsushita Y, et al. The GALNT6 LGALS3BP axis promotes breast cancer cell growth. Int J Oncol 2020; 56: 581-95.
Journals System - logo
Scroll to top